Press Releases

DAVIS, Calif., Jan. 09, 2020 (GLOBE NEWSWIRE) -- Marrone Bio (NASDAQ: MBII) (MBI), an international leader in sustainable bioprotection and plant health solutions, today announced a $13.0 million expansion of its existing accounts-receivable credit facility which now totals $20.0 million, as well as the addition of a $3.0 million inventory-backed credit facility to support the Company as it continues to expand its customer base.

Marrone Bio Innovations Inc. (NASDAQ: MBII) (MBI), an international leader in sustainable bioprotection and plant health solutions, today announced that two of its biofungicide products-Stargus® and Regalia®-have been approved by the United States Environmental Protection Agency (EPA) for indoor and outdoor use on hemp plants.

Marrone Bio (NASDAQ: MBII) (MBI), an international leader in sustainable bioprotection and plant health solutions, today announced the results of new U.S. field trials of its next-generation nematicide/insecticide, which showed superior control of yield-robbing insects and nematodes in corn.

Marrone Bio Innovations, Inc. (NASDAQ: MBII) (MBI), an international leader in sustainable bioprotection and plant health solutions, announced today that its 2019 field trial results for biology-based seed treatments in Europe demonstrated improved yields and cost-effective control of soil insects and nematodes that are equivalent to or better than current industry standards.